X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (1171) 1171
myristic acid (946) 946
myristic acids - metabolism (794) 794
biochemistry & molecular biology (738) 738
humans (733) 733
myristic acid - metabolism (562) 562
molecular sequence data (443) 443
amino acid sequence (433) 433
index medicus (371) 371
protein processing, post-translational (308) 308
cell line (301) 301
kinetics (277) 277
mice (276) 276
rats (264) 264
phosphorylation (227) 227
acylation (222) 222
cell membrane - metabolism (215) 215
male (215) 215
protein binding (215) 215
cell biology (209) 209
research article (207) 207
proteins (205) 205
lipids (193) 193
palmitic acid (193) 193
fatty acids (185) 185
transfection (183) 183
cells, cultured (177) 177
fatty acids - metabolism (172) 172
mutation (171) 171
myristoylation (160) 160
base sequence (156) 156
myristic acid - chemistry (153) 153
signal transduction (149) 149
palmitic acids - metabolism (148) 148
research (144) 144
recombinant proteins - metabolism (140) 140
biophysics (139) 139
virology (138) 138
female (136) 136
expression (134) 134
binding sites (133) 133
cattle (130) 130
cells (122) 122
analysis (115) 115
plasma-membrane (114) 114
calcium - metabolism (112) 112
membrane proteins - metabolism (109) 109
protein conformation (108) 108
binding (106) 106
models, molecular (106) 106
myristic acids - pharmacology (105) 105
substrate specificity (104) 104
electrophoresis, polyacrylamide gel (102) 102
acyltransferases - metabolism (101) 101
physiological aspects (101) 101
viruses (100) 100
molecular weight (99) 99
activation (98) 98
protein (95) 95
proteins - metabolism (94) 94
structure-activity relationship (94) 94
saturated fatty acids (93) 93
mutagenesis, site-directed (92) 92
enzyme activation (90) 90
protein structure, tertiary (89) 89
identification (87) 87
metabolism (87) 87
myristic acids - chemistry (87) 87
nutrition & dietetics (85) 85
gtp-binding proteins - metabolism (84) 84
in vitro techniques (84) 84
cloning, molecular (83) 83
multidisciplinary sciences (83) 83
palmitic acid - metabolism (83) 83
tritium (82) 82
protein kinase c - metabolism (80) 80
time factors (80) 80
recombinant proteins - chemistry (78) 78
article (77) 77
myristic acid - pharmacology (77) 77
cos cells (74) 74
blotting, western (73) 73
sequence homology, amino acid (73) 73
enzymes (72) 72
life sciences (72) 72
escherichia-coli (71) 71
pharmacology & pharmacy (71) 71
saccharomyces-cerevisiae (71) 71
chromatography, high pressure liquid (70) 70
gene expression (70) 70
membrane proteins (70) 70
adult (68) 68
gene (67) 67
recombinant fusion proteins - metabolism (65) 65
fatty acids - analysis (64) 64
biosynthesis (62) 62
calcium-binding proteins - metabolism (60) 60
gene products, gag - metabolism (60) 60
hela cells (60) 60
lipid metabolism (60) 60
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2020) 2020
Japanese (24) 24
French (8) 8
Russian (5) 5
German (4) 4
Chinese (1) 1
Spanish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Acta Biochimica Polonica, ISSN 0001-527X, 2015, Volume 62, Issue 3, pp. 499 - 507
Fatty acids (FAs) are one the most essential substances in intrauterine human growth. They are involved in a number of energetic and metabolic processes,... 
Pregnancy | Fatty acids | Fetal metabolism | FULL-TERM BABIES | fatty acids | SN-2 POSITION | fetal metabolism | BIOCHEMISTRY & MOLECULAR BIOLOGY | pregnancy | ESCHERICHIA-COLI | PRETERM INFANTS | ORGANIC-ACIDS | MYRISTIC ACID | DOCOSAHEXAENOIC ACID | PLACENTAL FUNCTION | INTRAUTERINE GROWTH RESTRICTION
Journal Article
Journal of Hepatology, ISSN 0168-8278, 2015, Volume 62, Issue 6, pp. 1398 - 1404
Graphical abstract 
Gastroenterology and Hepatology | 3-hydroxy-3-methylglutaryl-CoA reductase | Stearoyl-CoA desaturase | Non-alcoholic fatty liver disease | Lipogenesis | FGF19 | 3-hydroxy-3-methylglutaryl- CoA reductase | FXR | NONALCOHOLIC STEATOHEPATITIS | AGONISTS | NUCLEAR RECEPTOR | CHOLESTEROL-METABOLISM | TRANSPORT | FEEDBACK-REGULATION | LIVER | GASTROENTEROLOGY & HEPATOLOGY | EXPRESSION | ADIPOSE-TISSUE | Ursodeoxycholic Acid - administration & dosage | Oleic Acid - metabolism | Bile Acids and Salts - biosynthesis | Humans | Liver - metabolism | Bile Acids and Salts - metabolism | Non-alcoholic Fatty Liver Disease - metabolism | Intra-Abdominal Fat - metabolism | Obesity, Morbid - drug therapy | Non-alcoholic Fatty Liver Disease - drug therapy | Ursodeoxycholic Acid - pharmacology | Stearoyl-CoA Desaturase - biosynthesis | Liver - drug effects | Receptors, Cytoplasmic and Nuclear - antagonists & inhibitors | Lipid Metabolism - drug effects | Intra-Abdominal Fat - drug effects | Obesity, Morbid - metabolism | Physiological aspects | Obesity | Ursodiol | Deoxycholic acid | Index Medicus | BAs, bile acids | nCEH, neutral cholesterol ester hydrolase | ApoB, apolipoprotein B | LDLR, low density lipoprotein receptor | FGF19, fibroblast growth factor 19 | VLDL, very low density lipoproteins | ABC, ATP-binding cassette | TGs, triglycerides | NAFLD, non-alcoholic fatty liver disease | OA, oleic acid | C4, 7α-hydroxy-4-cholesten-3-one | SHP, small heterodimer partner | SREBP1c, sterol regulatory element-binding protein-1c | CA, cholic acid | PA, palmitic acid | FATP1, fatty acid transport protein 1 | UDCA, ursodeoxycholic acid | FAs, fatty acides | HMGCR, 3-hydroxy-3-methylglutaryl-CoA reductase | vWAT, visceral white adipose tissue | SCD, stearoyl-Coa desaturase | CYP7A1, cholesterol 7α-hydroxylase | NASH, non-alcoholic steatohepatitis | FXR, farnesoid X receptor | CDCA, chenodeoxycholic acid | MA, myristic acid | FASN, fatty acid synthase | MTTP, microsomal triglyceride transfer protein | SA, stearic acid | NONALCOHOLIC | FATTY LIVER-DISEASE | Gastroenterology & Hepatology | Endokrinologi och diabetes | STEATOHEPATITIS | PLACEBO-CONTROLLED TRIAL | COA DESATURASE | Endocrinology and Diabetes
Journal Article
Journal Article
Biochemical Pharmacology, ISSN 0006-2952, 08/2017, Volume 138, pp. 185 - 192
Human carbonyl reductase 1 (CBR1), a member of the short-chain dehydrogenase/reductase (SDR) superfamily, reduces a variety of carbonyl compounds including... 
Carbonyl reductase | Acyl-CoA | Inhibitory selectivity | Food-drug interaction | Fatty acid | DEHYDROGENASES | LOCALIZATION | IN-VITRO METABOLISM | MECHANISMS | POTENT INHIBITORS | IMPACT | RESISTANCE | PHARMACOLOGY & PHARMACY | UP-REGULATION | EXPRESSION | MODULATION | Oxidoreductases - antagonists & inhibitors | Palmitic Acid - metabolism | Humans | Drug Resistance, Neoplasm | Neoplasm Proteins - antagonists & inhibitors | Neoplasm Proteins - metabolism | Stearic Acids - metabolism | Alcohol Oxidoreductases - genetics | Sugar Alcohol Dehydrogenases - genetics | Fatty Acids, Nonesterified - metabolism | Intestinal Mucosa - enzymology | Alcohol Oxidoreductases - antagonists & inhibitors | Sugar Alcohol Dehydrogenases - antagonists & inhibitors | Acyl Coenzyme A - metabolism | Binding Sites | Sugar Alcohol Dehydrogenases - metabolism | Binding, Competitive | Recombinant Proteins - metabolism | Oxidoreductases - metabolism | Oxidoreductases - genetics | Food-Drug Interactions | Palmitoyl Coenzyme A - metabolism | Recombinant Proteins - chemistry | Alcohol Oxidoreductases - metabolism | Myristic Acid - metabolism | Cell Line, Tumor | Mutation | Physiological aspects | Fatty acids | Monounsaturated fatty acids | Anthracyclines | Colon cancer | Cytochrome P-450 | Drug resistance | Saturated fatty acids | Omega-3 fatty acids | Index Medicus
Journal Article
Diabetologia, ISSN 0012-186X, 5/2009, Volume 52, Issue 5, pp. 882 - 890
Previous studies have shown relationships between fatty acid ratios in adipose tissue triacylglycerol (TG), adipocyte size and measures of insulin sensitivity.... 
insulin sensitivity | dietary fatty acids | triacylglycerol | Medicine & Public Health | Human Physiology | stearic acid | stearoyl-CoA desaturase | Metabolic Diseases | Internal Medicine | saturated fatty acids | Adipocytes | de novo lipogenesis | Triacylglycerol | Insulin sensitivity | Dietary fatty acids | De novo lipogenesis | Stearoyl-CoA desaturase | Stearic acid | Saturated fatty acids | FATTY-ACID-COMPOSITION | CELL-SIZE | CARBOHYDRATE | DIABETES-MELLITUS | METABOLISM | GLUCOSE | ENDOCRINOLOGY & METABOLISM | RESISTANCE | HUMAN OBESITY | COA DESATURASE ACTIVITY | EXPRESSION | Palmitic Acid - metabolism | Obesity - complications | Humans | RNA, Messenger - genetics | Gene Expression Regulation | Insulin Resistance | Adipocytes - cytology | Reference Values | Mitochondria - metabolism | Lipids - biosynthesis | Diabetes Mellitus, Type 2 - epidemiology | Stearic Acids - metabolism | Triglycerides - metabolism | Adipose Tissue - metabolism | Myristic Acid - metabolism | Biopsy | Adipocytes - metabolism | Polymerase Chain Reaction | Triglycerides - blood | Diabetic Angiopathies - epidemiology | Fatty Acids, Nonesterified - blood | Blood Glucose - metabolism | Fatty Acids - metabolism | Diabetes Mellitus, Type 2 - complications | Adipose tissues | Triglycerides | Messenger RNA | Insulin | Analysis | Glucose metabolism | RNA | Genes | Glucose | Gene expression | Dextrose
Journal Article
Journal Article
BBA - Molecular and Cell Biology of Lipids, ISSN 1388-1981, 09/2018, Volume 1863, Issue 9, pp. 939 - 947
Journal Article
American Journal of Physiology - Endocrinology and Metabolism, ISSN 0193-1849, 06/2014, Volume 306, Issue 12, pp. E1378 - E1387
Incomplete beta-oxidation of fatty acids in mitochondria is a feature of insulin resistance and type 2 diabetes mellitus (T2DM). Previous studies revealed that... 
Acylcarnitine | β-oxidation | Inflammation | TLR | Pattern recognition receptors | OXIDATION | PHYSIOLOGY | acylcarnitine | SATURATED FATTY-ACIDS | INDUCED INSULIN-RESISTANCE | pattern recognition receptors | TOLL-LIKE RECEPTOR-2 | OBESITY | inflammation | beta-oxidation | ENDOCRINOLOGY & METABOLISM | EXPRESSION | Phosphorylation | Toll-Like Receptor 2 - agonists | Toll-Like Receptor 2 - antagonists & inhibitors | Toll-Like Receptor 2 - genetics | Humans | Carnitine - metabolism | Diabetes Mellitus, Type 2 - metabolism | MAP Kinase Signaling System | Receptors, Pattern Recognition - antagonists & inhibitors | Receptors, Pattern Recognition - metabolism | Macrophages - secretion | Cyclooxygenase 2 - genetics | Diabetes Mellitus, Type 2 - immunology | Myeloid Differentiation Factor 88 - antagonists & inhibitors | Receptors, Pattern Recognition - agonists | Carnitine - analogs & derivatives | Macrophages - immunology | Recombinant Proteins - metabolism | Myristic Acids - metabolism | Cyclooxygenase 2 - chemistry | Cytokines - secretion | Gene Silencing | Myeloid Differentiation Factor 88 - genetics | Enzyme Induction | Recombinant Proteins - chemistry | Toll-Like Receptor 2 - metabolism | Macrophage Activation | Myeloid Differentiation Factor 88 - agonists | Macrophages - metabolism | Animals | Cyclooxygenase 2 - metabolism | Cell Line, Tumor | Receptors, Pattern Recognition - genetics | Mice | Protein Processing, Post-Translational | Myeloid Differentiation Factor 88 - metabolism | Cell Line, Transformed | Docosahexaenoic Acids - metabolism | Type 2 diabetes | Physiological aspects | Insulin resistance | Cellular signal transduction | Research | Diabetes
Journal Article
The FEBS Journal, ISSN 1742-464X, 12/2015, Volume 282, Issue 24, pp. 4714 - 4726
Mitochondrial trifunctional protein and long‐chain 3‐hydroxyacyl‐CoA dehydrogenase deficiencies are fatty acid oxidation disorders biochemically characterized... 
mitochondrial permeability transition | long‐chain 3‐hydroxy fatty acid | calcium homeostasis | heart | mitochondrial bioenergetics | long-chain 3-hydroxy fatty acid | INNER MEMBRANE | BIOCHEMISTRY & MOLECULAR BIOLOGY | MTP DEFICIENCIES | PYRIDINE-NUCLEOTIDES | LIVER MITOCHONDRIA | BRAIN MITOCHONDRIA | SKELETAL-MUSCLE | CALCIUM UNIPORTER | TRIFUNCTIONAL PROTEIN-DEFICIENCY | G1528C MUTATION | BETA-OXIDATION DISORDERS | Nervous System Diseases - enzymology | Mitochondrial Myopathies - metabolism | Rhabdomyolysis - enzymology | Mitochondria, Heart - metabolism | Mitochondrial Swelling - drug effects | Rats, Wistar | Humans | Mitochondria, Heart - drug effects | Membrane Potential, Mitochondrial - drug effects | Cardiomyopathies - enzymology | Lipid Metabolism, Inborn Errors - enzymology | Mitochondrial Membranes - drug effects | Oxidative Phosphorylation - drug effects | Adenosine Triphosphate - metabolism | Nervous System Diseases - metabolism | NADP - metabolism | Mitochondrial Membrane Transport Proteins - metabolism | Myristic Acids - metabolism | Lipid Metabolism, Inborn Errors - metabolism | Enzyme Inhibitors - pharmacology | Mitochondria, Heart - enzymology | Calcium Channel Blockers - pharmacology | Organ Specificity | Mitochondrial Membranes - metabolism | Rhabdomyolysis - metabolism | Long-Chain-3-Hydroxyacyl-CoA Dehydrogenase - metabolism | Animals | Calcium Signaling - drug effects | Mitochondrial Trifunctional Protein - metabolism | Cardiomyopathies - metabolism | Cell Membrane Permeability - drug effects | Mitochondrial Myopathies - enzymology | Long-Chain-3-Hydroxyacyl-CoA Dehydrogenase - deficiency | Palmitic Acids - metabolism | Mitochondrial Trifunctional Protein - deficiency | Deregulation | Mitochondrial DNA | Permeability | Fatty acids | Heart | Homeostasis | Dehydrogenases
Journal Article
Science, ISSN 0036-8075, 10/2011, Volume 334, Issue 6055, pp. 528 - 531
Journal Article